Vineet Laboratories share news and announcements
NSE: VINEETLABBSE: 543298Pharmaceuticals & BiotechnologySmall Cap
Last close ₹36.23down ₹0.96 (2.58%)BSE ₹35.55
Share price at the NSE close on 23 Oct 2026. Previous close ₹37.19.
52-week range of traded prices to 23 Oct 2026
₹27.96Low, 9 Mar 2026₹49.99High, 30 Oct 2025
- Next results date: the board meets on 26 Oct 2026 to consider: financial results and other business matters.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹70 Cr3,234th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,53,94574.5% delivered
Vineet Laboratories share news and announcements
207 announcements, routine notices left out, newest first. Page 4 of 5.
Jun 2023
May 2023
Apr 2023
Feb 2023
23 Feb · Legal
Exchange has sought clarification from Vineet Laboratories Limited for the quarter ended 31-Dec-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is awaited.
Nov 2022
29 Nov · Related Party Transaction
Oct 2022
Sep 2022
1 Sep · Legal
Exchange has sought clarification from Vineet Laboratories Limited with respect to announcement dated 30-Aug-2022 informing about Outcome of Board Meeting.On the basis of aforesaid announcement, the Company is required to provide/clarify the following: 1. Brief profile (in case of appointment) The response of the company is awaited.1 Sep · Corporate action
Aug 2022
Jul 2022
Jun 2022
13 Jun · Related Party Transaction
May 2022
Apr 2022
9 Apr · Legal
The exchange asked on 5 Apr 2022
Feb 2022
12 Feb · Board meeting
Dec 2021
Nov 2021
10 Nov · Board meeting
Oct 2021
Sep 2021
6 Sep · Legal
Exchange has sought clarification from Vineet Laboratories Limited for the quarter ended 30-Jun-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
Aug 2021
31 Aug · Board meeting